News

1

Single-dose tafenoquine 150mg tablets in palm of hand

Colombia approves single-dose medicine to prevent relapse of P. vivax malaria

healthworkers participating in a training.

Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand

Meeting participants looking at camera

Event Highlights: The Indo-Pacific Regulatory Strengthening Program (RSP) Forum, 2022

PAVE meeting participants facing the camera

Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange

Speakers at the Symposium

Exploring new tools for P. vivax elimination in Brazil

Photo of the poster

Event Highlights from the 2022 International Conference on Plasmodium vivax Research (ICPvR)

children sitting under a mosquito bed net.

Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration

quote and photo of person quoted

P. vivax radical cure in Latin America: regional coordination to advance malaria elimination

microbiology laboratory in Porto Velho, Brazil

First real-world use of new protocol for P. vivax case management in Brazil – a Health Ministry and MMV collaboration

quote and photo of people quoted

New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

Gloved hands to perform G6PD STANDARD test

STANDARD G6PD Test receives regulatory approval by the Australian Therapeutic Goods Administration

APMEN VxWG Chair and co-Chair looking at screen

New Chair and co-Chair of the APMEN Vivax Working Group announced

Pages

1

Events